close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cbd Life Sciences Inc (OP:CBDL)

0.0004 -0.0001 (-20.00%)
Streaming Delayed Price Updated: 3:46 PM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cbd Life Sciences Inc

< Previous 1 2 3 4 Next >
CBD Life Sciences Inc. (CBDL) Lands Major Order from Bronx Dispensary "Smoking Scholars," Signaling Explosive Growth Ahead for CBD-Infused Drinks Division
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Secures Landmark Agreement with Bronx Powerhouse Dispensary Smoking Scholars
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Announces LOI With New Jersey Dispensary, Unlocking New Revenue Channels & Strategic Growth Opportunities
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Huge Momentum Following NECANN New Jersey 2025
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Announces President Trump Confirms Marijuana Rescheduling Is Under Consideration
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Releases New CBD Suppositories for Vaginal & Rectal Relief
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Announces New Powerful 500MG THC Delta-8 Gummy
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Launches Mushroom Powder Capsules
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Announces Company Will Exhibit at the NECANN Cannabis Conference in Atlantic City, NJ
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Announces National Expansion into Las Vegas Resorts & Hotels
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Nears Final Lease Agreement for Second High-Traffic Retail Location in Premier Arizona Mall, Signaling Major Expansion Phase
Via ACCESS Newswire
CBDL Announces Strategic Rollout on Vibe Performance Network, Elevating 8000MG Pain Cream to National Streaming Audiences
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Reports 1,502.30% Revenue Increase from January to May 2025
Via ACCESS Newswire
CBDL Launches New Mushroom Supplement Drink & Smoothie Bar
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Announces Open Market Share Buyback
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Announces 3.5 Billion Share Reduction From the Authorization
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Announces New Manufacturing Deal With A Southwest-Based Company
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Announces New Manufacturing Deal With A Columbian Company
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Announces Groundbreaking 100MG Full Spectrum CBD Gummy Geared Toward Mental Health & Focus
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Company Online Sales Up 500%
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Powers Forward with Disruptive Brain-Boosting Mushroom Applications
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Looking to Acquire a Cannabis Growth License in North Las Vegas
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Reports Stunning 622% Revenue Growth From June to November 2024
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Closes on LOI for Potential $8 Million Revenue Cannabis Dispensary
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Launches Passion Fuel Cordyceps Complex - A Powerful Sexual Enhancement Supplement
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Gears Up for Cave Creek Bike Week 2025
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) Announces Its Official Launch on Groupon.com
Via ACCESS Newswire
CBD Life Sciences Inc. (CBDL) in Final Stages to Sell CBD Products on DoorDash Platform
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented Growth
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Announces New Delta-8 100MG Gummies Designed to Support Individuals Living With Alzheimer’s
Via ACCESSWIRE
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today